Universitätsklinikum Ulm

Hemolysis, hemolytic markers, and mortality in sepsis: a scoping review (2025) Bünger V, Scholz S, Russ M, Weber-Carstens S, Graw JA Journal article, Review article Artificial intelligence as treatment support in breast cancer: current perspectives (2025) Lukac S, Putz F, De Micheli G, Corti C, Janni W, Tolaney SM, Curigliano G, et al. Journal article, Review article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study (2025) Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, et al. Journal article The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors (2025) Braun T, Huesmann S, Pfister K, Friedl TW, Hartkopf A, Pantel K, Mehmeti F, et al. Journal article Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025) Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, et al. Journal article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Mutation T9I in Envelope confers autophagy resistance to SARS-CoV-2 Omicron (2025) Klute S, Nchioua R, Cordsmeier A, Vishwakarma J, Koepke L, Alshammary H, Jung C, et al. Journal article Pawsitive impact: How pet contact ameliorates adult inflammatory stress responses in individuals raised in an urban environment (2025) Langgartner D, Weimer K, Brunner-Weisser J, Winkler R, Mannes M, Huber-Lang M, Sterrett JD, et al. Journal article Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study (2025) Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, et al. Journal article